Porcine somatotropin (pST) and certain beta-adrenergic agonists are po
tent metabolic modifiers that can improve performance in pigs. Pigs tr
eated with either compounds utilize feed more efficiently and are lean
er than controls. Comparative slaughter data clearly demonstrate that
pST and some beta-agonists stimulate protein deposition. Porcine somat
otropin decreases lipid deposition, but this is not the case for all b
eta-agonists. Somatotropin decreases lipid deposition through decreasi
ng adipose tissue sensitivity to insulin, inhibiting lipogenesis, and
perhaps stimulating lipolysis. Although lipolysis is increased during
pST treatment of growing pigs, the greatest consequence is decreased l
ipogenesis. Although under controlled conditions certain beta-agonists
stimulate lipolysis and inhibit lipogenesis, the limited metabolic st
udies suggest that at doses that are most efficacious for enhanced pro
tein deposition, there are limited effects on lipid metabolism. In par
t, this may be due to desensitization of adipose tissue beta-adrenergi
c receptors and possibly a consequence of antagonism of beta-receptors
.